Neuropediatrics 2009; 40(3): 120-125
DOI: 10.1055/s-0029-1243167
Original Article

© Georg Thieme Verlag KG Stuttgart · New York

Epilepsy in Patients with Propionic Acidemia

E. Haberlandt1 , C. Canestrini1 , M. Brunner-Krainz2 , D. Möslinger3 , K. Mussner4 , B. Plecko2 , S. Scholl-Bürgi1 , W. Sperl5 , K. Rostásy1 , D. Karall1
  • 1Clinical Department of Pediatrics, Division of Neonatology, Neuropediatrics and Inherited Metabolic Diseases, Medical University of Innsbruck, Innsbruck, Austria
  • 2University Children's Hospital Graz, Graz, Austria
  • 3University Children's Hospital Vienna, Vienna, Austria
  • 4Clinical Department of Pediatrics, Hospital Sterzing, Sterzing, Italy
  • 5Clinical Department of Pediatrics, Paracelsus University, Salzburg, Austria
Weitere Informationen

Publikationsverlauf

received 01.05.2009

accepted 27.10.2009

Publikationsdatum:
17. Dezember 2009 (online)

Preview

Abstract

Propionic acidemia (PA) is an autosomal recessively inherited defect of propionyl-CoA carboxylase with an incidence of approximately 1:50 000. There are few reports on the occurrence of EEG findings and development of epilepsy in patients with PA. Retrospectively, the data of 17 patients with PA from one Italian and four Austrian centers were evaluated concerning EEG findings and the development of epilepsy. Nine patients showed a disturbance of background activity, as well as epileptiform discharges. All nine patients with pathological EEG discharges developed seizures compatible with the definition of symptomatic epilepsy. Five of these nine patients showed fever induced seizures at the beginning. Two of them suffered from symptomatic absence epilepsy. Six of the nine patients with seizures were treated with antiepileptic drugs (AED), which were tolerated without side-effects. Four patients showed photosensitivity, which so far has never been reported in PA. We hypothesize that patients with PA are prone to cortical dysfunction caused by one or several pathological metabolites – leading to changes in background and epileptiform activity with a high manifestation rate of clinical seizures.

References

Correspondence

Dr. Edda Haberlandt

Clinical Department of Pediatrics

Division of Neuropediatrics and Inherited Metabolic Diseases

Medical University Innsbruck

Anichstraße 35

6020 Innsbruck

Austria

Telefon: +43/512/504 236 00

Fax: +43/512/504 232 47

eMail: edda.haberlandt@uki.at